In the field of Social anxiety and Anxiolytic Sagnik Bhattacharyya studies Anxiety. In his work, he performs multidisciplinary research in Anxiolytic and Anxiety. He conducts interdisciplinary study in the fields of Psychiatry and Clinical psychology through his works. In his works, he conducts interdisciplinary research on Clinical psychology and Psychiatry. Sagnik Bhattacharyya merges Internal medicine with Endocrinology in his study. His multidisciplinary approach integrates Endocrinology and Internal medicine in his work. He conducts interdisciplinary study in the fields of Cannabis and Cannabidiol through his research. In his work, he performs multidisciplinary research in Cannabidiol and Effects of cannabis. Sagnik Bhattacharyya performs multidisciplinary study on Effects of cannabis and Cannabis in his works.
His Schizophrenia (object-oriented programming) research includes themes of Internal medicine, Receptor and Cannabidiol, Cannabis. His Internal medicine study frequently intersects with other fields, such as Tetrahydrocannabinol. The study of Receptor is intertwined with the study of Tetrahydrocannabinol in a number of ways. He performs integrative Cannabidiol and Effects of cannabis research in his work. Sagnik Bhattacharyya undertakes multidisciplinary investigations into Cannabis and Effects of cannabis in his work. In his study, he carries out multidisciplinary Psychiatry and Pharmacology research. In his works, he undertakes multidisciplinary study on Pharmacology and Psychiatry. While working in this field, he studies both Neuroscience and Functional magnetic resonance imaging. While working in this field, Sagnik Bhattacharyya studies both Functional magnetic resonance imaging and Neuroscience.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology.
Sagnik Bhattacharyya;Paul D Morrison;Paolo Fusar-Poli;Paolo Fusar-Poli;Rocio Martin-Santos.
Neuropsychopharmacology (2010)
Cannabis and anxiety: a critical review of the evidence
José Alexandre Crippa;Antonio Waldo Zuardi;Rocio Martín-Santos;Sagnik Bhattacharyya.
Human Psychopharmacology-clinical and Experimental (2009)
Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing.
Paolo Fusar-Poli;José Alexandre de Souza Crippa;Sagnik Bhattacharyya;Stefan J. Borgwardt.
Archives of General Psychiatry (2009)
Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report:
José Alexandre S Crippa;Guilherme Nogueira Derenusson;Thiago Borduqui Ferrari;Lauro Wichert-Ana.
Journal of Psychopharmacology (2011)
Structural and Functional Imaging Studies in Chronic Cannabis Users: A Systematic Review of Adolescent and Adult Findings
Albert Batalla;Sagnik Bhattacharyya;Murat Yucel;Paolo Fusar-Poli.
PLOS ONE (2013)
Glutamatergic dysfunction in OCD.
Kaushik Chakrabarty;Sagnik Bhattacharyya;Rita Christopher;Sumant Khanna.
Neuropsychopharmacology (2005)
Modulation of mediotemporal and ventrostriatal function in humans by Delta9-tetrahydrocannabinol: a neural basis for the effects of Cannabis sativa on learning and psychosis.
Sagnik Bhattacharyya;Paolo Fusar-Poli;Stefan Borgwardt;Rocio Martin-Santos.
Archives of General Psychiatry (2009)
Neuroimaging in cannabis use: a systematic review of the literature
R. Martin-Santos;A. B. Fagundo;J. A. Crippa;Z. Atakan.
Psychological Medicine (2010)
Acute Effects of a Single, Oral dose of d9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) Administration in Healthy Volunteers
R. Martin-Santos;J. A. Crippa;J. A. Crippa;A. Batalla;Sagnik Bhattacharyya.
Current Pharmaceutical Design (2012)
Presynaptic Striatal Dopamine Dysfunction in People at Ultra-high Risk for Psychosis: Findings in a Second Cohort
Alice Egerton;Christopher A. Chaddock;Christopher A. Chaddock;Toby T. Winton-Brown;Toby T. Winton-Brown;Michael A.P. Bloomfield.
Biological Psychiatry (2013)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
King's College London
Royal Holloway University of London
Universidade de São Paulo
King's College London
King's College London
University of Melbourne
University of Lübeck
King's College London
University of Barcelona
Brighton and Sussex Medical School
École Polytechnique Fédérale de Lausanne
University of North Carolina at Chapel Hill
University of Maryland, College Park
Heriot-Watt University
Khalifa University
Medical College of Wisconsin
Gembloux Agro-Bio Tech
Universidade de São Paulo
University of Seville
University of Nevada, Las Vegas
United States Geological Survey
Namweza Center
Pompeu Fabra University
University of Vermont
University of Manchester
National Institutes of Health